Variant report
Variant | nsv1030263 |
---|---|
Chromosome Location | chr8:85293666-85332024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544965399 | chr8:85297803-85297804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533618666 | chr8:85297832-85297833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188543862 | chr8:85297870-85297871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560137946 | chr8:85297885-85297886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181384766 | chr8:85297887-85297888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539363922 | chr8:85297894-85297895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556378536 | chr8:85297909-85297910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185232846 | chr8:85297913-85297914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563432905 | chr8:85297953-85297954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200306244 | chr8:85297965-85297966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531663375 | chr8:85297977-85297978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182053671 | chr8:85297982-85297983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73298773 | chr8:85298023-85298024 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs575015947 | chr8:85298061-85298062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540728521 | chr8:85298092-85298093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148961260 | chr8:85298187-85298188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377285077 | chr8:85303224-85303225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184394232 | chr8:85303248-85303249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540595827 | chr8:85303268-85303269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560806064 | chr8:85303318-85303319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114475910 | chr8:85303329-85303330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561376568 | chr8:85303358-85303359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7834453 | chr8:85303400-85303401 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs16912783 | chr8:85303403-85303404 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs7816160 | chr8:85303408-85303409 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs567739328 | chr8:85303409-85303410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533747959 | chr8:85303459-85303460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189277967 | chr8:85303476-85303477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570751450 | chr8:85303488-85303489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7819778 | chr8:85303537-85303538 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs181857995 | chr8:85303549-85303550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556438687 | chr8:85303562-85303563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7820097 | chr8:85303565-85303566 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs7838135 | chr8:85303599-85303600 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs555075165 | chr8:85303606-85303607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186105394 | chr8:85303709-85303710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141210173 | chr8:85303736-85303737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143627526 | chr8:85303740-85303741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369332579 | chr8:85303761-85303762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189342148 | chr8:85303765-85303766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371082915 | chr8:85303945-85303946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7820544 | chr8:85303949-85303950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs181451061 | chr8:85303961-85303962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185937511 | chr8:85304076-85304077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527374272 | chr8:85304079-85304080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73300751 | chr8:85304088-85304089 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs570345382 | chr8:85304101-85304102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568922351 | chr8:85304167-85304168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191362513 | chr8:85304205-85304206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs145605632 | chr8:85304293-85304294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:85297800-85298200 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr8:85303200-85304000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr8:85303200-85304200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr8:85303800-85304400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:85304000-85305600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr8:85304000-85309400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr8:85304200-85304800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr8:85304400-85305200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr8:85304800-85305000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr8:85305000-85309200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr8:85305200-85305400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:85309200-85309400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr8:85309200-85309600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr8:85309400-85310000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr8:85319200-85319600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr8:85319200-85319600 | Enhancers | Fetal Brain Male | brain |
17 | chr8:85324800-85325200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |